Skip to main content
SpringerLink
Log in

Histologisches Grading beim Mammakarzinom

Histological grading of breast cancer

  • Pathologie
  • Published:
Wiener klinisches Magazin Aims and scope

Zusammenfassung

Das histologische Grading ist die älteste zellorientierte Methode zur Beurteilung der Tumorbiologie und Prognose beim Mammakarzinom. Dieser Übersichtsartikel gibt neben einem historischen Rückblick detaillierte und für die Praxis gedachte Hinweise zum histologischen Grading. Es wird außerdem erörtert, weshalb auch noch im Zeitalter der molekularen Pathologie der genauen Bestimmung des histologischen Grades weiterhin große Bedeutung zukommt.

Abstract

From a historical perspective, histological grading was the earliest cell-based method for assessing tumor biology and the prognosis of breast cancer. This review article provides detailed and practical instructions for grading of breast cancer in routine diagnostics. Furthermore, the increasing relevance of precise histological grading in the era of molecular pathology is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Conard NJ, Malina M, Munzel SC (2009) New flutes document the earliest musical tradition in southwestern Germany. Nature 460:737–740

    CAS  PubMed  Google Scholar 

  2. Hansemann D (1892) Ueber die Anaplasie der Geschwulstzellen und die asymmetrische Mitose. Virchows Arch Pathol Anat Physiol Klin Med 129:436–449

    Article  Google Scholar 

  3. Sistrunk WE, Maccarty WC (1922) Life expectancy following radical amputation for carcinoma of the breast: A clinical and pathologic study of 218 cases. Ann Surg 75:61–69

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Kaiser P, Karrer K (1972) Steinthal- oder TNM-System beim Mammakarzinom. Z Krebsforsch 77:274–278

    Article  CAS  Google Scholar 

  5. Greenough RB (1925) Varying degrees of malignancy in cancer of the breast. J Cancer Res 9:453–463

    Google Scholar 

  6. Patey DH, Scarff RW (1928) Histology in the prognosis of carcinoma of the breast. Lancet 211:801–804

    Article  Google Scholar 

  7. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Stenkvist B, Westman-Naeser S, Vegelius J, Holmquist J, Nordin B et al (1979) Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32:979–985

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–410

    Article  CAS  PubMed  Google Scholar 

  10. Elston CW, Ellis IO (2002) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 41(3a):151–152

    Article  CAS  PubMed  Google Scholar 

  11. Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ et al (2006) Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol 19:195–207

    Article  PubMed  Google Scholar 

  12. Weigelt B, Reis-Filho JS (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6:718–730

    Article  CAS  PubMed  Google Scholar 

  13. Perou CM, Sorlie T, Eisen MB, Rijn M van de, Jeffrey SS et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752

    Article  CAS  PubMed  Google Scholar 

  14. Lakhani SR, Ellis I, Schnitt S, Tan PH, Vijver M van de (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon

    Google Scholar 

  15. Robbins P, Pinder S, Klerk N de, Dawkins H, Harvey J et al (1995) Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 26:873–879

    Article  CAS  PubMed  Google Scholar 

  16. Dabbs D (2012) Breast pathology. Elsevier Saunders, Philadelphia

    Google Scholar 

  17. Kronqvist P, Kuopio T, Collan Y (2000) Morphometric grading of breast cancer: thresholds for tubular differentiation. Br J Cancer 82:1656–1661

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gluz O, Nitz U, Christgen M, Kates RE, Shak S et al (2016) The WSG phase III planB trial: first prospective outcome data for the 21-gene recurrence score assay and concordance of prognostic markers by central and local pathology assessment. J Clin Oncol doi:10.1200/JCO.2015.63.5383

    PubMed  Google Scholar 

  19. Wasielewski R von, Klopper K, Luck HJ, Kreipe H (2006) Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker. Pathologe 27:337–345

    Article  Google Scholar 

  20. Kronqvist P, Kuopio T, Collan Y (1998) Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade. Br J Cancer 78:800–805

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rosen PP (2008) Rosen’s breast pathology, 3. Aufl. Lippincott Williams & Wilkins, Dover

    Google Scholar 

  22. Mengel M, Wasielewski R von, Wiese B, Rudiger T, Muller-Hermelink HK, Kreipe H (2002) Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 198:292–299

    Article  PubMed  Google Scholar 

  23. Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC et al (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103:1656–1664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Polley MY, Leung SC, Gao D, Mastropasqua MG, Zabaglo LA et al (2015) An international study to increase concordance in Ki67 scoring. Mod Pathol 28(6):778–786

    Article  PubMed  Google Scholar 

  25. Christgen M, Ahsen S von, Christgen H, Langer F, Kreipe H (2015) The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer. Hum Pathol 46:1341–1349

    Article  PubMed  Google Scholar 

  26. Papadimitriou M, Kaptanis S, Polymeropoulos E, Mitsopoulos G, Stogiannis D et al (2015) Nuclear grade plus proliferation grading system for invasive ductal carcinoma of the breast: validation in a tertiary referral hospital cohort. Am J Clin Pathol 144:837–843

    Article  CAS  PubMed  Google Scholar 

  27. Abdel-Fatah TM, Powe DG, Agboola J, Adamowicz-Brice M, Blamey RW et al (2010) The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. J Pathol 220:419–434

    CAS  PubMed  Google Scholar 

  28. Abdel-Fatah TM, Powe DG, Ball G, Lopez-Garcia MA, Habashy HO et al (2010) Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer. J Pathol 222:388–399

    Article  PubMed  Google Scholar 

  29. Louwman MW, Vriezen M, Beek MW van, Nolthenius-Puylaert MC, Sangen MJ van der et al (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121:127–135

    Article  CAS  PubMed  Google Scholar 

  30. Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26:3006–3014

    Article  PubMed  Google Scholar 

  31. Erber R, Gluz O, Brunner N, Kreipe HH, Pelz E et al (2015) Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial. Breast Cancer Res Treat 150:279–288

    Article  CAS  PubMed  Google Scholar 

  32. Rakha EA, El-Sayed ME, Menon S, Green AR, Lee AH, Ellis IO (2008) Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 111:121–127

    Article  PubMed  Google Scholar 

  33. Daveau C, Baulies S, Lalloum M, Bollet M, Sigal-Zafrani B et al (2014) Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma. Br J Cancer 110:2195–2200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kwok TC, Rakha EA, Lee AH, Grainge M, Green AR et al (2010) Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Histopathology 57:212–219

    Article  PubMed  PubMed Central  Google Scholar 

  35. Pinder SE, Provenzano E, Earl H, Ellis IO (2007) Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology 50:409–417

    Article  CAS  PubMed  Google Scholar 

  36. Pierga JY, Mouret E, Laurence V, Dieras V, Savigioni A et al (2003) Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response. Eur J Cancer 39:1089–1096

    Article  PubMed  Google Scholar 

  37. Langer F, Luck HJ, Kreipe HH (2004) Morphological response to therapy of breast carcinoma. Pathologe 25:455–460

    Article  CAS  PubMed  Google Scholar 

  38. Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G et al (1994) Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy. Geburtshilfe Frauenheilkd 54:552–558

    Article  CAS  PubMed  Google Scholar 

  39. Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C et al (2015) Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol doi:10.1093/annonc/mdv161

    PubMed  PubMed Central  Google Scholar 

  40. Dalton LW, Page DL, Dupont WD (1994) Histologic grading of breast carcinoma. A reproducibility study. Cancer 73:2765–2770

    Article  CAS  PubMed  Google Scholar 

  41. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ et al (1995) Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198

    Article  PubMed  Google Scholar 

  42. Davis BW, Gelber RD, Goldhirsch A, Hartmann WH, Locher GW et al (1986) Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 58:2662–2670

    Article  CAS  PubMed  Google Scholar 

  43. Paik S, Shak S, Tang G, Kim C, Baker J et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pathologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str.1, 30625, Hannover, Deutschland

    Matthias Christgen,  Florian Länger &  Hans H. Kreipe

Authors
  1. Matthias Christgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florian Länger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans H. Kreipe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Christgen.

Ethics declarations

Interessenkonflikt

M. Christgen, F. Länger und H. Kreipe geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Dieser Beitrag wurde in der Zeitschrift Der Pathologe 2016 ・ 37:328–336, DOI 10.1007/s00292-016-0182-8 erstveröffentlicht. Zweitveröffentlichung mit freundlicher Genehmigung der Autoren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Christgen, M., Länger, F. & Kreipe, H.H. Histologisches Grading beim Mammakarzinom. Wien klin Mag 20, 86–93 (2017). https://doi.org/10.1007/s00740-017-0173-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00740-017-0173-2

Schlüsselwörter

Keywords

Search

Navigation